C18 hydroxy fatty acids as markers of lipid peroxidation ex vivo and in vivo

References

• Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifica-tions of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–24.
   Google Scholar
• Witztum JL. The oxidation hypothesis of athero-sclerosis. Lancet 1994; 344: 793–5.
   PubMed Web of Science ®Google Scholar
• Kaikkonen J, Nyyssönen K, Porkkala-Sarataho E, Poulsen HE, Metsä-Keteld T, Hayn M, Salonen R, Salonen JT. Effect of oral coenzyme Q10 supplementation on the oxidation resistance of human VLDL-F LDL fraction: absorption and antioxidative properties of oil and granule-based preparations. Free Radic Biol Med 1997; 22: 1195–202.
   PubMed Web of Science ®Google Scholar
• Salonen JT. Markers of oxidative damage and antioxidant protection: assessment of LDL oxida-tion. Free Radic Res 2000; 33: 41–6.
   Google Scholar
• Dekkers JC, van Doornen LJ, Kemper HC. The role of antioxidant vitamins and enzymes in the prevention of exercise-induced muscle damage. Sports Med 1996; 21: 213–38.
   PubMed Web of Science ®Google Scholar
• Salonen JT, Yld-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid athero-sclerosis. Lancet 1992; 339: 883–7.
   PubMed Web of Science ®Google Scholar
• Neuzil J, Thomas SR, Stocker R. Requirement for, promotion, or inhibition by alpha-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic Biol Med 1997; 22: 57–71.
   Google Scholar
• Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992; 13: 341–90.
   PubMed Web of Science ®Google Scholar
• Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci USA 1991; 88: 1646–50.
   Google Scholar
• Kanter MM, Nolte LA, Holloszy JO. Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise. J Appl Physiol 1993; 74: 965–9.
   Google Scholar
• Clarkson PM, Thompson HS. Antioxidants: what role do they play in physical activity and health? Am J Clin Nutr 2000; 72: 637S–46S.
   Google Scholar
• Fuller CJ, Grundy SM, Norkus EP, halal I. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers. Atherosclerosis 1996; 119: 139–50.
   PubMed Web of Science ®Google Scholar
• Gutteridge JM. Aspects to consider when detect-ing and measuring lipid peroxidation. Free Radic Res Commun 1986; 1: 173–84.
   PubMedGoogle Scholar
• Leaf DA, Kleinman MT, Hamilton M, Barstow TJ. The effect of exercise intensity on lipid peroxidation. Med Sci Sports Exerc 1997; 29: 1036— 9.
   PubMed Web of Science ®Google Scholar
• Drury JA, Nycyk JA, Cooke RV. Pentane measurement in ventilated infants using a commercially available system. Free Radic Biol Med 1997; 22: 895–900.
   PubMed Web of Science ®Google Scholar
• Breuer O, Björkhem I. Simultaneous quantifica-tion of several cholesterol autoxidation and monohydroxylation products by isotope-dilution mass spectrometry. Steroids 1990; 55: 185–92.
   PubMed Web of Science ®Google Scholar
• Salonen JT, Nyyssönen K, Salonen R, Porkkala-Sarataho E, Tuomainen TP, Diczfalusy U, Björkhem I. Lipoprotein oxidation and pro-gression of carotid atherosclerosis. Circulation 1997; 95: 840–5.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Roberts LJ 2nd. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol 1999; 300: 3–12.
   Google Scholar
• Nikkari T, Malo-Ranta U, Hiltunen T, Jaakkola 0, Yld-Herttuala S. Monitoring of lipoprotein oxidation by gas chromatographic analysis of hydroxy fatty acids. J Lipid Res 1995; 36: 200–7.
   Google Scholar
• Wilson R, Smith R, Wilson P, Shepherd MJ, Riemersma RA. Quantitative gas chromatography-mass spectrometry isomer-specific measurement of hydroxy fatty acids in biological samples and food as a marker of lipid peroxidation. Anal Biochem 1997; 248: 76–85.
   Google Scholar
• Costa CG, Dorland L, Holwerda U, de Almeida IT, Poll-The BT, Jakobs C, Duran M. Simulta-neous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid beta-oxidation disorders. Clin Chem 1998; 44: 463–71.
   Google Scholar
• Jones PM, Quinn R, Fennessey PV, Tjoa S, Goodman SI, Fiore S, Burlina AB, Rinaldo P, Boriack RL, Bennett MJ. Improved stable isotope dilution-gas chromatography mass spectrometry method for serum or plasma free 3-hydroxy-fatty acids and its utility for the study of disorders of mitochondrial fatty acid beta-oxidation. Clin Chem 2000; 46: 149–55.
   PubMed Web of Science ®Google Scholar
• Suarna C, Dean RT, Southwell-Keeley PT, Moore DE, Stocker R. Separation and character-ization of cholesteryl oxo- and hydroxy-linoleate isolated from human atherosclerotic plaque. Free Radic Res 1997; 27: 397–408.
   Google Scholar
• Krauss RM. Dietary and genetic effects on low-density lipoprotein heterogeneity. Annu Rev Nutr 2001; 21: 283–95.
   PubMed Web of Science ®Google Scholar
• Veerkamp MJ, de Graaf J, Bredie SJ, Hendriks JC, Demacker PN, Stalenhoef AF. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study. Arterioscler Thromb Vasc Biol 2002; 22: 274–82.
   PubMed Web of Science ®Google Scholar
• Nyyss6nen K, Kaikkonen J, Salonen JT. Char-acterization and determinants of an electronega-tively charged low-density lipoprotein in human plasma. Scand J Clin Lab Invest 1996; 56: 681–9.
   Google Scholar
• Salonen JT, Nyyssönen K, Salonen R, Lakka HM, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Lakka TA, Rissanen T, Leskinen L, Tuomainen TP, Valkonen VP, Ristonmaa U, Poulsen HE. Antioxidant supplementation in atherosclerosis prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 2000; 248: 377–86.
   PubMed Web of Science ®Google Scholar
• Turnham DI, Smith E, Flora PS. Concurrent liquid-chromatographic assay of retinol, tocopherol, I3-carotene, lycopene, and 13-cryptoxanthine in plasma, with tocopherol acetate as internal standard. Clin Chem 1988; 34: 377–81.
   Google Scholar
• Porkkala-Sarataho EK, Nyyssönen MK, Kaikkonen JE, Poulsen HE, Hayn EM, Salonen RM, Salonen JT. A randomized, single-blind, placebo-controlled trial of the effects of 200 mg a-tocopherol on the oxidation resistance of athero-genic lipoproteins. Am J Clin Nutr 1998; 68: 1034— 41.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 2nd ed. Oxford: Clarendon Press; 1989.
   Google Scholar
• Comporti M, Signorini C, Buonocore G, Ciccoli L. Iron release, oxidative stress and erythrocyte ageing. Free Radic Biol Med 2002; 32: 568–76.
   PubMed Web of Science ®Google Scholar
• Quinlan GJ, Evans TW, Gutteridge JM. Linoleic acid and protein thiol changes suggestive of oxidative damage in the plasma of patients with adult respiratory distress syndrome. Free Radic Res 1994; 20: 299–306.
   Google Scholar
• Browne RW, Armstrong D. HPLC analysis of lipid-derived polyunsaturated fatty acid peroxida-tion products in oxidatively modified human plasma. Clin Chem 2000; 46: 829–36.
   PubMed Web of Science ®Google Scholar
• Lenz ML, Hughes H, Mitchell JR, Via DP, Guyton JR, Taylor AA, Gotto AM, Smith CV. Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipo-protein. J Lipid Res 1990; 31: 1043–50.
   PubMed Web of Science ®Google Scholar
• Spiteller G. Linoleic acid peroxidation—the domi-nant lipid peroxidation process in low density lipoprotein—and its relationship to chronic dis-eases. Chem Phys Lipids 1998; 95: 105–62.
   PubMed Web of Science ®Google Scholar
• Chan HWS. Autoxidation of unsaturated lipids. London, UK: Academic Press; 1987.
   Google Scholar
• Wilson R, Lyall K, Smyth L, Fernie CE, Riemersma RA. Dietary hydroxy fatty acids are absorbed in humans: implications for the measurement of "oxidative stress" in vivo. Free Radic Biol Med 2002; 32: 162–8.
   Google Scholar
• Lynch SM, Morrow JD, Roberts JL 2nd, Frei B. Formation of non-cyclooxygenase-derived prosta-noids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest 1994; 93: 998–1004.
   Google Scholar
• Skoglund-Andersson C, Tang R, Bond MG, de Faire U, Hamsten A, Karpe F. LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men. Arterioscler Thromb Vasc Biol 1999; 19: 2422— 30.
   Google Scholar
• Demuth K, Myara I, Chappey B, Vedie B, Pech-Amsellem MA, Haberland ME, Moatti N. A cytotoxic electronegative LDL subfraction is present in human plasma. Arterioscler Thromb Vasc Biol 1996; 16: 773–83.
   PubMed Web of Science ®Google Scholar
• Calabresi L, Donati D, Pazzucconi F, Sirtori CR, Franceschini G. Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses. Atherosclerosis 2000; 148: 387 — 96.
   Google Scholar
• de Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb Vasc Biol 1991; 11: 298–306.
   PubMed Web of Science ®Google Scholar
• Avogaro P, Bon GB, Cazzolato G. Presence of a modified low density lipoprotein in humans. Atherosclerosis 1988; 8: 79–87.
   Google Scholar
• Bittolo-Bon G, Cazzolato G. Analytical capillary isotachophoresis of total plasma lipoproteins: a new tool to identify atherogenic low density lipoproteins. J Lipid Res 1999; 40: 170–7.
   Google Scholar